Study Stopped
The grant funding has expired
Efficacy of the Non-invasive Brain Stimulation Techniques for Lower Limb Recovery in Stroke Patients
1 other identifier
interventional
10
1 country
1
Brief Summary
This study is to compare the efficacy of two types of non-invasive brain stimulation (NIBS) in lower limb motor function recovery in stroke patients. The intervention will be tDCS (transcraniel direct current stimulation) or rTMS (repetitive transcraniel magnetic stimulation) plus conventional gait training for 10 days over 2 weeks. The study hypothesizes that:
- 1.When combined with conventional gait training, NIBS could improve the walking ability of stroke survivors.
- 2.NIBS will modulate cortex activity of the brain area representing the lower limbs.
- 3.The effects of NIBS might be related to some genetic factors. 45 subjects will be randomly divided into 3 groups, receiving tDCS plus conventional gait training, or rTMS plus conventional gait training, or sham tDCS plus conventional gait training.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable stroke
Started Feb 2016
Longer than P75 for not_applicable stroke
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 21, 2014
CompletedStudy Start
First participant enrolled
February 1, 2016
CompletedFirst Posted
Study publicly available on registry
September 30, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2020
CompletedApril 22, 2022
April 1, 2022
4.4 years
December 21, 2014
April 14, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
changes of " gait parameters" from baseline to post-intervention and 4 weeks after intervention
Gait analysis will be performed using the Tekscan walkway system. Subjects will be required to walk on a mat at their comfort speed. Gait parameters including step and stride parameters, symmetry scores, velocity, and cadence temporal will be collected and recorded while the subject is walking along the walkway.
before intervention, immediately after intervention, 4 weeks after intervention
Secondary Outcomes (7)
changes of "cortical excitability measured by TMS" from baseline to post-intervention and 4 weeks after intervention
before intervention, immediately after intervention, 4 weeks after intervention
changes of " Blood BDNF level" from baseline to post-intervention and 4 weeks after intervention
before intervention, immediately after intervention, 4 weeks after intervention
changes of " cortical excitability measured by fMRI" from baseline to post-intervention and 4 weeks after intervention
before intervention, immediately after intervention, 4 weeks after intervention
changes of " Psychological and cognitive properties" from baseline to post-intervention and 4 weeks after intervention
before intervention, immediately after intervention, 4 weeks after intervention
changes of walking speed measured by "10 meter walk test" from baseline to post-intervention and 4 weeks after intervention
before intervention, immediately after intervention, 4 weeks after intervention
- +2 more secondary outcomes
Study Arms (3)
tDCS+ rehab training
EXPERIMENTALtDCS will be applied 10 days, followed by conventional rehab training. Anodal stimulation will be conducted at the intensity of 2 mA and last for 20 minutes over the affected primary motor cortex of cortical representation of the tibialis anterior muscle.
rTMS+ rehab training
EXPERIMENTALrTMS will be applied 10 days, followed by conventional rehab training. Subjects will receive 10 Hz rTMS, and a total of 1200 pulses will be delivered for one treatment session.
sham tDCS+ rehab training
SHAM COMPARATORThe same stimulation parameters as tDCS treatment will be employed for the sham stimulation. However, the current will be applied for 30 seconds only, to give subjects the sensation of the stimulation.
Interventions
Conventional rehab training will be conducted daily for 10 days, after NIBS intervention.
tDCS will be applied 10 days, followed by conventional rehab training. Stimulation will be conducted at the intensity of 2 mA and last for 20 minutes. anode will be placed over the affected primary motor cortex (M1) of cortical representation of the tibialis anterior muscle (TA), while the cathode will be used as reference electrode and placed over the forehead of the unaffected side.
rTMS will be applied 10 days, followed by conventional rehab training. Subjects will receive 10 Hz rTMS, and a total of 1200 pulses will be delivered for one treatment session.
The same stimulation parameters as tDCS treatment will be employed for the sham stimulation. However, the current will be applied for 30 seconds only, to give subjects the sensation of the stimulation.
Eligibility Criteria
You may qualify if:
- For subjects receiving intervention:
- Male or female aged 21-80 years;
- First ever haemorrhagic or ischaemic subcortical stroke of 3-6 months prior to study enrolment;
- Functional Ambulatory Category 3 (requires not more than minimal assistance for walking);
- Be able to provide informed consent.
- For healthy subjects:
- Male or female aged 21-80 years;
- Physically healthy;
- Be able to provide informed consent.
You may not qualify if:
- For subjects receiving intervention:
- Severe claustrophobia;
- pregnancy;
- cardiac pacemakers;
- orthodontics (braces);
- metal implant;
- presence of other non MRI-compatible ferromagnetic implants;
- history of epilepsy;
- sensorimotor disturbance due to other causes other than stroke;
- severe pain in the lower limbs affecting gait;
- uncontrolled medical conditions including hypertension, diabetes mellitus and unstable angina;
- major depression and a history of psychotic disorders (Subject with BDI score more than 30 will be excluded).
- For healthy subjects:
- Cardiovascular diseases;
- Diabetes mellitus;
- +2 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National University Hospital
Singapore, 119228, Singapore
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Effie Chew, MD
National University Hospital, Singapore
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 21, 2014
First Posted
September 30, 2016
Study Start
February 1, 2016
Primary Completion
July 1, 2020
Study Completion
July 1, 2020
Last Updated
April 22, 2022
Record last verified: 2022-04